Login

Switch On Your HIV Smarts.

Disappointing results from “kick and kill” HIV cure study, explained

Disappointing results from “kick and kill” HIV cure study, explained

, by Emily Land

Researchers say that although the two-pronged treatment failed to reduce the viral reservoir, we shouldn’t lose hope that a “kick and kill” strategy might someday be successful. Read More

PrEP scales up, HIV incidence declines

PrEP scales up, HIV incidence declines

, by Liz Highleyman

We’re starting to see the effects of PrEP on population-level measures of HIV incidence, but progress is uneven. Read More

PrEP advocate Damon Jacobs: Vaping can be harm reduction

PrEP advocate Damon Jacobs: Vaping can be harm reduction

, by Damon Jacobs

There’s a flaw in San Francisco’s plan to ban flavored tobacco products, and it may have negative consequences for people who use vaping products to quit smoking cigarettes. Read More

Ending hepatitis C means including people who inject drugs

Ending hepatitis C means including people who inject drugs

, by Emily Land

Innovative HCV cure initiatives in San Francisco prioritize high-needs people who may still be actively injecting drugs. Read More

CROI 2018: A roundup of the most exciting PrEP news & research

CROI 2018: A roundup of the most exciting PrEP news & research

, by Liz Highleyman

Liz Highleyman summarizes the PrEP and HIV prevention research presented recently at the domestic HIV conference, CROI, including a new possible PrEP drug, real world PrEP effectiveness, and more. Read More